---
edited: 2024-03-02
tags:
---
- Mechanism of action: increases the sensitivity of calcium-sensing receptors in parathyroid glands to circulating Ca2+ â†’ inhibition of PTH release
- Indications 
	- Parathyroid carcinoma with hypercalcemia
	- pHPT and severe hypercalcemia in patients who do not undergo parathyroidectomy  [2]
	- sHPT in patients with CKD who are on dialysis
- Adverse effects include hypocalcemia, nausea, vomiting, and diarrhea.
- Contraindications: [[hypocalcemia]]

---
